Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-11-14Clinical Trial Update: A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease [Phase 3]
The Phase 3 study of Mongersen (GED-0301) for active Crohn's disease has been withdrawn by the sponsor Celgene.
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2) [Phase 3]
Phase 3 trial update for an oral ferric iron formulation in quiescent Crohn's disease shows safety and efficacy data for iron deficiency ane…
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: Comparison of Intracorporeal and Extracorporeal Anastomoses for Minimally Invasive Right Colectomy
Completed clinical trial comparing intracorporeal versus extracorporeal anastomoses for minimally invasive right colectomy; the update notes…
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: Fistulodesis Pilot Study for Closure of Perianal Fistulae [NA]
This entry provides a trial update for a pilot study of fistulodesis aimed at closing perianal fistulae, including Crohn's disease, sponsore…
-
CLINICAL_TRIALS research · 2017-10-26Clinical Trial Update: SSAT 054: Non Genetic Factors in the Pathogenesis of IBD in Twins
This entry reports a clinical trial (SSAT 054) investigating non-genetic factors in the pathogenesis of inflammatory bowel disease in twins,…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-10-25Clinical Trial Update: Magnetic Resonance Imaging of Motility in Crohn's 2 [NA]
Completed clinical trial evaluating MRI-based motility assessment in Crohn's disease.
-
FDA approval · 2017-10-17FDA Approved: BUDESONIDE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for Budesonide submitted by Padagis US LLC, expanding regulatory authorization for the product. The …
-
CLINICAL_TRIALS trial_result · 2017-10-16Clinical Trial Update: A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease [Phase 2]
An open-label Phase 2 study assesses long-term therapy with tofacitinib (CP-690,550) over 48 weeks in Crohn's disease; results were posted i…
-
FDA approval · 2017-10-13FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for ustekinumab (Stelara) from Janssen Biotech, Inc., potentially expanding indications or updat…
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: Comparison of the Performance of SB2-Infliximab With Originator Infliximab in the Measure of Serum Concentrations in Serum
The document summarizes a clinical trial comparing the pharmacokinetic performance of the biosimilar SB2-infliximab to the originator inflix…
-
CLINICAL_TRIALS trial_result · 2017-10-10Clinical Trial Update: Cimzia Versus Mesalamine for Crohn's Recurrence [Phase 4]
Phase 4 trial comparing Cimzia to mesalamine for Crohn's disease recurrence has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2017-10-06Clinical Trial Update: Trial of High Dose Vitamin D in Patient's With Crohn's Disease [Phase 4]
Phase 4 trial investigating high-dose vitamin D in Crohn's disease was terminated; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-09-25Clinical Trial Update: The NOR-SWITCH Study [Phase 4]
Phase 4 clinical trial update for NOR-SWITCH study; completed with multiple inflammatory diseases assessed.
-
CLINICAL_TRIALS trial_result · 2017-09-21Clinical Trial Update: High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in Children [Phase 2]
Phase 2 trial update for high-dose oral 4-aminosalicylic acid (PASER) to control acute flares in children with Crohn's disease; study termin…
-
CLINICAL_TRIALS trial_result · 2017-09-19Clinical Trial Update: A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease [Phase 3]
Phase 3 trial completed for GSK1605786A in moderately-to-severely active Crohn's disease; results posted.
-
CLINICAL_TRIALS trial_result · 2017-09-14Clinical Trial Update: Open-Label Extension Study of GSK1605786A [Phase 3]
Open-label extension study results for GSK1605786A in Crohn's disease, a Phase 3 trial that has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-09-07Clinical Trial Update: GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease [Phase 3]
Phase 3 trial update for GSK1605786A in maintenance of remission for Crohn's disease; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2017-09-06Clinical Trial Update: Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD) [Phase 1, Phase 2]
Clinical trial update for FURESTEM-CD in moderately active Crohn's disease (Phase 1/Phase 2) with unknown status.
-
CLINICAL_TRIALS trial_result · 2017-09-05Clinical Trial Update: Extension Study of MT-1303 in Subjects With Crohn's Disease [Phase 2]
Phase 2 extension study update for MT-1303 in Crohn's Disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: A Study To Monitor Long-Term Treatment With PF-00547659 [Phase 2]
Phase 2 trial update for long-term treatment with PF-00547659 in Crohn's disease; results completed and posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: Rapidity of Response to Adalimumab Treatment in Patients With Crohn´s Disease [Phase 4]
This update reports results from a Phase 4 study evaluating the speed of response to adalimumab in patients with moderate-to-severe Crohn's …
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: Manitoba Inflammatory Bowel Disease Cohort Study
Clinical trial update shows the Manitoba inflammatory bowel disease cohort study is completed, focusing on Crohn's disease and Ulcerative co…
-
CLINICAL_TRIALS research · 2017-08-21Clinical Trial Update: Bacteria & Inflammation in the Gut (BIG) Study
Update on the Bacteria & Inflammation in the Gut (BIG) study investigating Crohn's disease. The current status of the trial is unknown.
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease [Phase 3]
A Phase 3 clinical trial of GSK1605786A in Crohn's disease was terminated; results were posted in 2017.
-
FDA approval · 2017-08-16FDA Approved: TYSABRI — Supplemental Application (Biogen Inc.)
The FDA approved Biogen's supplemental application for TYSABRI (natalizumab), resulting in changes to the drug's labeling.